Showing results (261-270 of 300) with videos related to
Sort By:
Pageof 30
Academic Medicine : Journal of the Association of American Medical Colleges|October 10, 2003
Medical humanities at New York University School of Medicine: an array of rich programs in diverse settingsSharon K Krackov, Richard I Levin, Veronica Catanesé, et al.Molecular Ecology Resources|October 10, 2020
Contaminations contaminate common databasesStaffan Bensch, Mizue Inumaru, Yukita Sato, et al.International Journal for Parasitology|June 21, 2011
Hippoboscid-transmitted Haemoproteus parasites (Haemosporida) infect Galapagos Pelecaniform birds: evidence from molecular and morphological studies, with a description of Haemoproteus iwaIris I Levin, Gediminas Valkiūnas, Diego Santiago-Alarcon, et al.The Journal of Experimental Medicine|November 14, 1997
Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptorsM C Montesinos, P Gadangi, M Longaker, et al.Bioorganic & Medicinal Chemistry Letters|July 24, 2009
3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein bindingWei Li, Yonghan Hu, Jianchang Li, et al.Human Molecular Genetics|October 11, 2002
Molecular and pathological effects of a modifier gene on deficiency of the sodium channel Scn8a (Na(v)1.6)Jennifer A Kearney, David A Buchner, Georgius De Haan, et al.Bioorganic & Medicinal Chemistry Letters|April 26, 2011
Macrocyclic lactams as potent Hsp90 inhibitors with excellent tumor exposure and extended biomarker activityChristoph W Zapf, Jonathan D Bloom, Jamie L McBean, et al.Bioorganic & Medicinal Chemistry Letters|February 24, 2001
The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-positionJ I Levin, M T Du, J F DiJoseph, et al.Bioorganic & Medicinal Chemistry Letters|July 1, 2011
Discovery of a stable macrocyclic o-aminobenzamide Hsp90 inhibitor which significantly decreases tumor volume in a mouse xenograft modelChristoph W Zapf, Jonathan D Bloom, Zhong Li, et al.Journal of Medicinal Chemistry|November 30, 2004
Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitorsAranapakam M Venkatesan, Jamie M Davis, George T Grosu, et al.Pageof 30